187 related articles for article (PubMed ID: 31661139)
1. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
[TBL] [Abstract][Full Text] [Related]
3. CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway.
Zhang LZ; Huang LY; Huang AL; Liu JX; Yang F
Life Sci; 2018 Aug; 207():420-427. PubMed ID: 29959029
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
6. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
[TBL] [Abstract][Full Text] [Related]
8. Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.
Liang Y; Zhang T; Shi M; Zhang S; Guo Y; Gao J; Yang X
J Cell Biochem; 2019 Apr; 120(4):6237-6249. PubMed ID: 30335900
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
[TBL] [Abstract][Full Text] [Related]
10. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
11. iRhom2 in the pathogenesis of oral squamous cell carcinoma.
Agwae ME; Shaw RJ; Triantafyllou A; Greaney FST; Ben Salah K; Risk JM
Mol Biol Rep; 2020 May; 47(5):3987-3992. PubMed ID: 32236893
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
13. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
[TBL] [Abstract][Full Text] [Related]
14. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
15. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
Wei H; Zhang JJ; Tang QL
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
Wang DW; You D; Dong J; Liu TF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156
[TBL] [Abstract][Full Text] [Related]
17. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract][Full Text] [Related]
18. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
[TBL] [Abstract][Full Text] [Related]
19. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
